Michael J. Fisher

faculty photo
Associate Professor of Pediatrics at the Children's Hospital of Philadelphia
Attending Physician, Center for Childhood Cancer Research and Division of Oncology, Children's Hospital of Philadelphia
Director, Neuro-Oncology Fellowship Program, Children’s Hospital of Philadelphia
Director, Neurofibromatosis Program, Children’s Hospital of Philadelphia
Chief, Neuro-Oncology Section, Division of Oncology, Children’s Hospital of Philadelphia
Department: Pediatrics

Contact information
Center for Childhood Cancer Research and Division of Oncology
The Children’s Hospital of Philadelphia
Colket Translational Research Building - 10th Floor
3501 Civic Center Blvd
Philadelphia, PA 19104
Office: (215)590-2800

Eberhard-Karls Universitaet, Tubingen, Germany, 1987.
B.A. (Psychology, Summa cum Laude)
Amherst College, 1989.
Harvard Medical School (cum Laude), 1994.
Permanent link

Description of Itmat Expertise

Dr. Fisher is interested in the management of brain tumors and tumors related to neurofibromatosis type 1 and in new imaging modalities for evaluation of plexiform neurofibromas and brain tumors.

Selected Publications

Hobbie W, Ogle S, Reilly M, Barakat L, Lucas M, Ginsberg JP, Fisher MJ, Volpe EM, Hardie T, Deatrick JA: Adolescent and Young Adult Survivors of Childhood Brain Tumors: Life after Treatment in their Own Words. Cancer Nursing 39(2): 134-143, 2016.

Armstrong CL, Fisher MJ, Li Y, Lustig RA, Belasco JB, Minturn JE, Cole KA, Hill-Kayser CE, Batra S, Phillips PC : Neuroplastic Response following Radiotherapy for Pediatric Brain Tumors: A Pilot Study. International Journal of Radiation Oncology, Biology, Physics 95(3): 991-998, 2016.

de Blank PMK, Berman JI, Fisher MJ: Systemic Chemotherapy and White Matter Integrity in Tracts Associated with Cognition Among Children with Neurofibromatosis Type 1. Pediatric Blood & Cancer 63(5): 818-824, 2016.

Shah A, Minturn JE, Li Y, Belasco JB, Phillips PC, Kang T, Cole K, Waanders A, Pollack R, Didomenico C, Wildes C, Fisher MJ: Carboplatin Rechallenge after Hypersensitivity Reactions in Pediatric Patients with Low-Grade Glioma. Pediatric Blood Cancer 63(1): 21-26, 2016.

Plotkin SR, Davis SD, Robertson KA, Akshintala S, Allen JL, Fisher MJ, Blakeley J, Widemann B, Ferner RE, Marcus CL: Sleep and Pulmonary Outcomes for Clinical Trials of Airway Plexiform Neurofibromas in NF1. Neurology 87 (Suppl 1): S13–S20, 2016.

Levin MH, Armstrong GT, Broad JH, Zimmerman R, Bilaniuk LT, Feygin T, Liu GT, Fisher MJ: Risk of Optic Pathway Glioma in Children with Neurofibromatosis Type 1 and Optic Nerve Tortuosity or Nerve Sheath Thickening. Brit J Ophthalmol 100(4): 510-514, 2016.

de Blank PMK, Fisher MJ, Lu L, Leisenring WM, Ness KK, Sklar CA, Stovall M, Vukadinovich C, Robison LL, Armstrong GT, Krull KR: The Impact of Vision Loss Among Survivors of Childhood Central Nervous System Astroglial Tumors. Cancer 122(5): 730-739, 2016.

Packer RJ, Rood BR, Turner DC, Fisher M, Smith C, Young-Pouissant T, Goldman S, Lulla R, Banerjee A, Pollack I, Kun L, Onar-Thomas A, Wu S, Boyett JM, Fouladi M : Phase I and Pharmacokinetic Trial of PTC299 in Pediatric Patients with Refractory or Recurrent Central Nervous System Tumors: a PBTC Study J Neuro-Oncology 121 (1): 217-224, 2015.

Warrington NM, Sun T, Luo J, McKinstry RC, Parkin PC, Ganzhorn S, Spoljaric D, Albers AC, Merkelson A, Stewart DR, Stevenson DA, Viskochil D, Druley TE, Forys JT, Reilly KM, Fisher MJ, Tabori U, Allen JC, Schiffman JD, Gutmann DH, Rubin JB: The Cyclic AMP Pathway is a Sex-Specific Modifier of Glioma Risk in Type 1 Neurofibromatosis Patents. Cancer Research 75(1): 16-21, 2015.

Emoto C, Fukuda T, Mizuno T, Cox S, Schniedewind B, Christians U, Widemann BC, Fisher MJ, Weiss B, Perentesis J, Vinks AA: Age Dependent Changes in Sirolimus Metabolite Formation in Patients with Neurofibromatosis Type 1. Therapeutic Drug Monitoring 37(3): 395-399, 2015.

back to top
Last updated: 09/26/2016
The Trustees of the University of Pennsylvania